Lupin Q3 Results
- BSE: 500257
- NSE: LUPIN
- ISIN: INE326A01037
- Sector: Biotechnology & Drugs
BSE
2,010
-25.00 (-1.23%)
-25.00 (-1.23%)Volume17.80 K
Updated: Wed 7 Oct, 2026 | 15:01:21
NSE
2,011.20-18.10 (-0.89%)
-18.10 (-0.89%)Volume5.56 L
Updated: Wed 7 Oct, 2026 | 14:47:12
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Lupin Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 5,697.56 | 4,621.37 | 9.01% | 4,432.65 | 21.92% |
| Depreciation/ Amortization | 312.96 | 256.92 | -1.20% | 257.20 | 15.29% |
| Operating Income | 1,469.96 | 1,051.36 | -19.27% | 764.76 | 34.32% |
| Net Income | 1,175.55 | 852.58 | -20.46% | 613.12 | 37.47% |
| Other Operating Expenses Total | 1,936.62 | 1,666.99 | -2.17% | 1,560.13 | 14.19% |
| Net Income Before Taxes | 1,522.04 | 1,054.86 | -24.16% | 736.10 | 42.08% |
| Total Revenue | 7,167.52 | 5,672.73 | 1.70% | 5,197.41 | 24.27% |
| Selling/ General/ Admin Expenses Total | 1,143.28 | 1,007.52 | 3.41% | 889.24 | 16.14% |
| Diluted Normalized EPS | 42.13 | 18.64 | 30.53% | 13.41 | 125.44% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.